Venetoclax plus azacitidine in younger adults with acute myeloid leukemia beyond historical comparisons. Comment on: "Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy"
Open access0 citations
Abstract
Not available.
// Source
Institutions: Ningbo University, Ningbo University Affiliated Hospital